Allen K R
Department of Clinical Biochemistry, Leeds Teaching Hospitals, UK.
Clin Toxicol (Phila). 2006;44(2):147-53. doi: 10.1080/15563650500514434.
Confirmation of the presence of illicit drugs in human fluids by liquid chromatography linked to atmospheric pressure ionisation tandem mass spectrometry (LC/MS/MS) is becoming increasingly popular. A rapid LC/MS/MS method is described using reversed phase gradient elution chromatography on a 50 x 3 mm base deactivated C8 column with identification of drugs based on their Multiple Reaction monitoring (MRM) transitions, retention time, and co-elution of stable isotopic analogues where available. The method is used for drug confirmation following initial screening by immunoassay, and identification of drugs such as tramadol, for which no immunoassay is available. False positive results for tramadol were observed in cases where subjects were being treated with the commonly prescribed antidepressant drug venlafaxine. This was a result of the presence of the metabolite O-desmethylvenlafaxine, which has a similar transition to tramadol. This study highlights the need to consider drug metabolites, as well as parent drugs in interferences in LC/MS/MS methods.
通过液相色谱与大气压电离串联质谱联用(LC/MS/MS)技术确认人体体液中非法药物的存在正变得越来越普遍。本文描述了一种快速的LC/MS/MS方法,该方法采用反相梯度洗脱色谱,在一根50×3mm的去活C8柱上进行,基于药物的多反应监测(MRM)跃迁、保留时间以及在有可用稳定同位素类似物时的共洗脱情况来鉴定药物。该方法用于免疫分析法初步筛查后的药物确认,以及鉴定如曲马多这类没有免疫分析方法的药物。在受试者接受常用抗抑郁药文拉法辛治疗的病例中,观察到了曲马多的假阳性结果。这是由于代谢物O-去甲基文拉法辛的存在,其跃迁与曲马多相似。这项研究强调了在LC/MS/MS方法的干扰中需要考虑药物代谢物以及母体药物。